DCW Ltd (DCW)

Chemicals · Petrochemicals · NSE · Updated 1 September 2026
By StockFin Research Team AI-Assisted Analysis Source: BSE/NSE Filings
₹45.51 ↓ 37.99% (1Y)

🎯 Key Takeaways

  • DCW Ltd is in a strategic transition phase, shifting focus from commodity PVC to higher-margin Specialty Chemicals while executing a capital-intensive expansion in Synthetic Iron Oxide Pigments and power infrastructure to improve margins and achieve net debt freedom by FY27 end..
  • Revenue declined 11% QoQ to ₹542 in Q1FY27.
  • ⚠️ 1) PVC segment remains vulnerable to geopolitical and import duty volatility, with volumes declining 20% QoQ in Q1 FY2
Market Cap
₹1,343
P/E Ratio
18.8
P/B Ratio
2.40
ROE
12.7%
ROCE
9.6%
Debt/Equity
1.21
Div Yield
0.44%
Promoter
45.6%

📖 The Story

DCW Ltd is in a strategic transition phase, shifting focus from commodity PVC to higher-margin Specialty Chemicals while executing a capital-intensive expansion in Synthetic Iron Oxide Pigments and power infrastructure to improve margins and achieve net debt freedom by FY27 end.

📰 What's Happening

In Q1 FY27, DCW reported 14% YoY revenue growth but a 11% QoQ decline, pressured by PVC margin erosion due to West Asia disruptions and import duty changes. Specialty Chemicals drove 38% YoY revenue growth and 20% EBITDA growth at 29.1% margin, contributing 33% of total revenue. The company announced a ₹250 crore investment to expand Synthetic Iron Oxide capacity to 45,000 MT by FY29 and upgrade captive power infrastructure, alongside leadership transition with Sudarshan Ganapathy taking over as CEO. Management targets INR300 crore FY27 EBITDA and net debt freedom by FY27 end.

Source: Stock Announcements

📊 Quarterly Results (₹ Cr)

MetricJun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Revenue476539520609542
Operating Profit2932193810
OPM %6.0%5.9%3.6%6.3%1.8%
Net Profit111451835
EPS₹0.38₹0.47₹0.17₹0.61₹1.17

Revenue peaked at ₹609 crore in Q4 FY26 but declined sequentially to ₹542 crore in Q1 FY27, reflecting PVC volume weakness (-20% QoQ) and margin compression to 1.8% OPM from 6.3%. However, Specialty Chemicals delivered 38% YoY growth and improved EBITDA margin to 29.1%, offsetting commodity headwinds. Net profit fell to ₹35 crore in Q1 FY27 from ₹18 crore in Q4 FY26, indicating ongoing restructuring pressures despite strategic investments.

🔮 Management Outlook & What's Next

Management highlighted the Specialty Chemicals segment as a key growth engine and outlined a phased expansion of Synthetic Iron Oxide capacity, with 7,000 MT added by Q4 FY28 and full 45,000 MT capacity targeted by FY29. The CEO transition to Sudarshan Ganapathy is positioned as a move to drive operational efficiency and margin recovery. Forward guidance emphasizes breakeven in Basic Chemicals by Q2 and sustained EBITDA growth to reach INR300 crore in FY27, underpinning a shift toward higher-margin, defensible segments.

Extracted from official company announcements. Not StockFin.ai's opinion.

🏦 Balance Sheet (₹ Cr)

ItemMar 2015
Equity Capital43
Reserves517
Borrowings680
Total Liabilities1,846
Fixed Assets635
Investments0
Total Assets1,846

The migration to the concessional tax regime reduced deferred tax liabilities by INR34 crores, improving balance sheet efficiency. Despite ₹250 crore in planned capital expenditure for capacity expansion, management is targeting net debt freedom by FY27 end, suggesting deleveraging will be prioritized through operational cash flow and potential asset optimization, even as investments ramp up.

💰 Cash Flow Statement (₹ Cr)

ItemMar 2015
Operating+69
Investing-157
Financing+89
Net Cash Flow+1

👥 Shareholding Pattern

CategoryQ3FY26Q4FY26Q1FY27
Promoters45.1%45.4%45.6%
FII8.6%6.7%6.1%
DII0.0%0.0%0.1%
Public30.9%33.2%34.0%
# Shareholders1,08,4301,07,4751,08,567

FII holding increased from 6.12% in Q1 FY27 to 6.71% in Q4 FY26, indicating institutional accumulation, while DII and promoter stakes remained relatively stable. The growing number of shareholders (1,08,567 in Q1 FY27) reflects broadening retail interest. No pledging or significant dilution was observed, suggesting confidence in the company's restructuring narrative.

⚖️ Peer Comparison — Petrochemicals

Company MCap (₹ Cr) P/E ROCE ROE D/E
SPLPETRO 13,709 28.3 28.2% 20.4% 0.00
SOTL 4,717 11.4 31.8% 22.8% 0.00
STYRENIX 3,534 12.9 21.7% 20.0% 0.23
BEPL 3,012 15.1 25.5% 18.4% 0.00
PANAMAPET 2,846 5.9 39.3% 32.6% 0.05
MANALIPETC 1,401 7.8 20.0% 16.4% 0.04
DCW 1,343 18.8 9.6% 12.7% 1.21
TNPETRO 1,084 7.6 20.4% 15.6% 0.13
AGARIND 685 16.8 7.3% 6.5% 0.68
GOACARBON 338 -5.3% -58.3% 1.97

🔗 Peer Stock Analyses

⚠️ Risk Factors

1) PVC segment remains vulnerable to geopolitical and import duty volatility, with volumes declining 20% QoQ in Q1 FY27. 2) Margin recovery in Specialty Chemicals is critical but not guaranteed, as EBITDA margin compressed to 29.1% despite 38% revenue growth. 3) Execution risk around ₹250 crore capex deployment and timely capacity ramp-up by FY29. 4) Deferred tax benefits are one-time; future tax efficiency depends on sustained profitability.

📋 Recent Filings

🧠 Analyst's Read

DCW is undergoing a structural pivot from commoditized PVC to Specialty Chemicals, supported by targeted capex and leadership change, but near-term margin pressure and execution risks in expansion projects require close monitoring. Investors should watch for margin recovery inflection and debt reduction progress toward FY27 targets.

Based on filing content and financial data. Not a recommendation.

Read the full analysis

Quarterly trends, balance sheet, cash flow, peer comparison, and AI insights — sign up free to unlock.

Sign Up Free — Unlock Full Analysis

2 free AI queries per day.

Data sourced from stock announcements. Analysis generated by StockFin.ai.
For informational purposes only — not investment advice. Updated 2026-09-01.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when DCW files new disclosures

Track DCW filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track DCW — Free

Free account · 2 AI queries/day